Verastem Inc
Follow $VSTM
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $VSTM by emailVeridion Score
BETALOW CONF · 5 of 6 factors measuredHighest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Why is VSTM moving today?
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
VSTM overview
Related filings and maps
Congress activity in VSTM
No receipt-qualified Congressional disclosure is present for VSTM in the cached public ledger.
VSTM contract awards, year to date.
Public federal awards linked to this ticker.
VSTM lobbying filings, year to date.
Registered lobbying filings matched to Verastem Inc.